News

Keryx Biopharmaceuticals (Keryx) has received FDA Fast Track designation for KRX-0401 (Perifosine), an oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory

Roche has begun shipping additional quantities of oral suspension (liquid), Tamiflu (oseltamivir phosphate). The added supplies of Tamiflu will begin arriving in pharmacies nationwide and will continue to

The Society of Chemical Manufacturers and Affiliates (SOCMA) has appointed Lawrence Sloan as president and CEO of the association, effective February 10, 2010. Sloan succeeds Joseph Acker, who

Alexion Pharmaceuticals has provided updates on the regulatory review and approval of Alexion’s Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of supply

Phosphagenics has initiated Phase 1B clinical trial for its patented Oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems. The primary objective of the Phase 1B clinical trial is to

Shire has settled the litigation with Teva over Shire’s supply to Teva of an authorised generic version of Adderall XR. Shire has been supplying Teva with authorised generic

PTC Therapeutics (PTC) has received $1m challenge grant award from the National Heart, Lung, and Blood Institute (NHLBI) as part of the National Institutes of Health (NIH). The

Health Enhancement Products (HEPI) has reported that based on observations of ProAlgaZyme (PAZ) activity during tests for inflammation management, Wayne State University School of Medicine professor of pathology

Javelin Pharmaceuticals has submitted a New Drug Application (NDA) to the FDA for its investigational product candidate, Dyloject (diclofenac sodium) injection, for the management of acute moderate-to-severe pain